Premium
How to deal with multiple treatment or dose groups in randomized clinical trials? Another approach
Author(s) -
Boissel JeanPierre
Publication year - 2007
Publication title -
fundamental and clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.655
H-Index - 73
eISSN - 1472-8206
pISSN - 0767-3981
DOI - 10.1111/j.1472-8206.2007.00478.x
Subject(s) - test (biology) , medical physics , clinical trial , randomized controlled trial , computer science , medicine , intensive care medicine , psychology , surgery , paleontology , biology
The multiple test issue is a tricky one. There is no entirely correct solution. It is better to avoid it by careful thinking prior to beginning the experiment. In fundamental and clinical pharmacology, there are several established concepts that allow researchers to minimize the cases where the issue arises.